Genetic variants of CYP19 (aromatase) and breast cancer risk-Reference-Cited by-同舟云学术

Genetic variants of CYP19 (aromatase) and breast cancer risk

Published:2000-03 Issue:10 Volume:19 Page:1329-1333
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Kristensen Vessela Nedelcheva,Harada Nobuhiro,Yoshimura Noriko,Haraldsen Ellen,Lønning P E,Erikstein Bjørn,Kåresen Rolf,Kristensen Tom,Børresen-Dale Anne-Lise

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1203425.pdf

Reference19 articles.

1. Burak Jr WE, Quinn AL, Farrar WB and Brueggemeier RW . 1997 Breast Cancer Research and Treatment 44: 57–64

2. Durgam VR, Easton JA, Surya R and Tekmal RR . 1995 Biochimica et Biophysica Acta 1263: 89–92

3. Fisher CR, Graves KH, Parlow AF and Simpson ER . 1998 Proc Natl Acad Sci USA 95: 6965–6970

4. Hankinson SE, Willet WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL and Speizer FE . 1998 J Nat Cancer Inst 90: 1292–1299

5. Harada N, Ogawa H, Shozu M and Yamada K . 1992 Am J Hum Genet 51: 666–672

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. G-quadruplex formation within the promoter region of HSPB2 and its effect on transcription;Heliyon;2024-01

2. Rs10046, Rs1902023, Rs4148269 and Ugt2b17 Deletion in Tunisian Women's Hormone Receptor Positivebreast Cancer: Risk Factors and Prognostic;2023

3. The association between CYP17A1, CYP19A1, and HSD17B1 gene polymorphisms of estrogen synthesis pathway and ovarian cancer predisposition;Meta Gene;2022-02

4. Interactions between exposure to polycyclic aromatic hydrocarbons and xenobiotic metabolism genes, and risk of breast cancer;Breast Cancer;2021-08-05

5. CYP19A1 rs10046 Pharmacogenetics in Postmenopausal Breast Cancer Patients Treated with Aromatase Inhibitors: One-year Follow-up;Current Pharmaceutical Design;2020-12-30